Senior leadership realignment focused on continuing to deliver sales growth and enhanced profitability.EAGAN, MN / ACCESSWIRE / July 6, 2022...
LOS ANGELES, CA / ACCESSWIRE / July 6, 2022 / Marijuana Company of America, Inc. (OTC:MCOA) ("the Company"), which operates,...
VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it...
Company Invites Investors, Analysts, and Advisors to Attend Its Real-Time, Interactive Update/Q&A SessionSOUTH EASTON, MA / ACCESSWIRE / July 6,...
VANCOUVER, BC / ACCESSWIRE / July 6, 2022 / Clairvoyant Therapeutics, a Canadian biotech company, is pleased to announce it...
ANN ARBOR, MI / ACCESSWIRE / July 6, 2022 / Zomedica Corp. (NYSE American:ZOM) ('Zomedica' or the 'Company'), a veterinary...
NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Vanderbilt University Medical Center (VUMC) and Roivant Social Ventures (RSV) announced an...
New Capabilities and Clients are Fueling the Award-Winning Primary Care ServicePURCHASE, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:...
NEW YORK, July 06, 2022 (GLOBE NEWSWIRE) -- Better Choice Company Inc. (NYSE: BTTR) (the “Company” or “Better Choice”), a...
New Implant Offers Surgeons and Their Patients More Options to Customize Their Surgical OutcomesSANTA BARBARA, Calif., July 06, 2022 (GLOBE...
This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)...
CARLSBAD, Calif., July 06, 2022 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN), a diversified life sciences company focused on...
Warwick, NY, July 06, 2022 (GLOBE NEWSWIRE) -- Ozop Energy Solutions. Inc. (OZSC), is pleased to announce that it expects...
Since launching in Western Canada in 2019, TELUS Health’s Personal Health Record (PHR) solution has seen rapid growth helping more...
First clinical trial of Allocetra™ in patients with cancer builds upon promising preclinical studies demonstrating its broadly applicable immunotherapeutic effects...
First successful global gold standard pediatric Phase 3 trial ever conducted in cholestatic liver disease PEDFIC 1 & 2 studies...
INDIANAPOLIS, July 06, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating...
Implemented expense reductions including headcount during the second quarterLEXINGTON, Mass., July 06, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO),...
FREMONT, CA, July 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
Three Arm, Randomized, Double-Blind, Vehicle Controlled Study Will Test Two Doses of QRX003 Versus VehicleASHBURN, Va., July 06, 2022 (GLOBE...